Skip to content
Medlarge
  • Home
  • Lifestyle
  • Short News
  • Hospitals
  • In Conversation
  • Research
  • About
  • Privacy Policy
  • मेडलार्ज – हिन्दी

Tag: NTAGI

DCGI recommends Serum Institute’s qHPV vaccine against cervical cancer

June 16, 2022
The Subject Expert Committee of Drugs Controller General of India (DCGI) on Wednesday recommended Serum Institute’s indigenously developed quadrivalent human papillomavirus (qHPV) vaccine for cervical cancer patients....
Posted in Featured, Hospitals, Latest | Tagged DCGI, NTAGI

Trending

  • Chandipura virus Health minister urges enquiry against Secretary
  • Drugs Controller General of India Hypertension affects 1 in 3 adults worldwide: WHO
  • AIIMS AIIMS Delhi starts ABHA-based Scan and Share facility

Latest

  • Paras Medi Clinic

    Paras health launches community-focused initiative ‘Paras Medi Clinic’

  • Fortis Hospital Shalimar Bagh

    Special Rakhi gift: Brother donates liver to save sister’s toddler

  • Bihar kids fall sick after eating mid day meal

    Centre Restricts Cold Medicine Combinations for Children Below 4 Years

  • NMC

    50 thousand doctors trained in AI, 20 Lakhs in CPR: NMC chairperson on India’s medical education

Medlarge
  • Healthy Citizens are the greatest assets any country can have – this is the central idea that drives the Medlarge team to bring the news that makes your life a little bit healthier and prosperous. Learn more
  • Connect With Medlarge on Facebook Connect With Medlarge on WhatsApp Connect With Medlarge on X (Twitter)
Categories
  • Alternative Medicines
  • COVID-19 Updates
  • Education
  • Featured
  • G20
Latest Posts
  • Why including HPV vaccine in national program is waste of public fund, explains top epidemiologist
  • From IAS to UNIDO: Naresh Nandan Prasad’s Extraordinary Journey in ‘Small Cogs in a Large Wheel’
Medlarge
  • About
  • Contact
  • Privacy
  • मेडलार्ज – हिन्दी
© 2026 | medlarge.com